These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 25378085)
61. Prevalence of human papillomavirus infection in adolescent girls before reported sexual debut. Smith JS J Infect Dis; 2014 Sep; 210(6):835-6. PubMed ID: 24740632 [No Abstract] [Full Text] [Related]
62. RETRACTION: Increased incidence of cervical cancer in Sweden: Possible link with HPV vaccination. Editors of Indian J Med Ethics Indian J Med Ethics; 2018; 3(3):246. PubMed ID: 30044233 [TBL] [Abstract][Full Text] [Related]
63. Statement on corrections. Editors IJME Indian J Med Ethics; 2018; 3(3):245. PubMed ID: 30044234 [TBL] [Abstract][Full Text] [Related]
64. More Youth Vaccinated for HPV. Kuehn B JAMA; 2018 Oct; 320(14):1426. PubMed ID: 30304433 [No Abstract] [Full Text] [Related]
65. Change in population prevalences of human papillomavirus after initiation of vaccination: the high-throughput HPV monitoring study. Söderlund-Strand A; Uhnoo I; Dillner J Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2757-64. PubMed ID: 25380734 [TBL] [Abstract][Full Text] [Related]
66. The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems. Pellegrino P; Perrone V; Pozzi M; Carnovale C; Perrotta C; Clementi E; Radice S Immunol Res; 2015 Feb; 61(1-2):90-6. PubMed ID: 25381482 [TBL] [Abstract][Full Text] [Related]
67. Use of HPV vaccine in males and females. Cifu AS; Davis AM JAMA; 2014 Nov; 312(18):1920-1. PubMed ID: 25387190 [No Abstract] [Full Text] [Related]
68. Could the human papillomavirus vaccines drive virulence evolution? Murall CL; Bauch CT; Day T Proc Biol Sci; 2015 Jan; 282(1798):20141069. PubMed ID: 25429011 [TBL] [Abstract][Full Text] [Related]
69. Projected impact of Cervarix® vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom. Van Effelterre T; Hogea C; Taylor S Hum Vaccin Immunother; 2014; 10(7):1794. PubMed ID: 25424784 [TBL] [Abstract][Full Text] [Related]
70. Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation. Mesher D; Cuschieri K; Hibbitts S; Jamison J; Sargent A; Pollock KG; Powell N; Wilson R; McCall F; Fiander A; Soldan K J Clin Pathol; 2015 Feb; 68(2):135-40. PubMed ID: 25410654 [TBL] [Abstract][Full Text] [Related]
71. Epidemiological and clinical reasons for vaccination against pertussis and influenza in pregnant women. Nitsch-Osuch A; Korzeniewski K; Gawlak M; Życińska K; Wardyn K; Kuchar E Adv Exp Med Biol; 2015; 849():11-21. PubMed ID: 25398316 [TBL] [Abstract][Full Text] [Related]
73. Sexual transmission of oral human papillomavirus infection among men. Dahlstrom KR; Burchell AN; Ramanakumar AV; Rodrigues A; Tellier PP; Hanley J; Coutlée F; Franco EL Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2959-64. PubMed ID: 25392180 [TBL] [Abstract][Full Text] [Related]
74. A sudden onset of a pseudo-neurological syndrome after HPV-16/18 AS04-adjuvated vaccine: might it be an autoimmune/inflammatory syndrome induced by adjuvants (ASIA) presenting as a somatoform disorder? Poddighe D; Castelli L; Marseglia GL; Bruni P Immunol Res; 2014 Dec; 60(2-3):236-46. PubMed ID: 25388965 [TBL] [Abstract][Full Text] [Related]
75. Adolescent vaccine co-administration and coverage in New York City: 2007-2013. Sull M; Eavey J; Papadouka V; Mandell R; Hansen MA; Zucker JR Pediatrics; 2014 Dec; 134(6):e1576-83. PubMed ID: 25384490 [TBL] [Abstract][Full Text] [Related]
76. Human papillomavirus vaccination. Brotherton JM Br J Hosp Med (Lond); 2014 Nov; 75 Suppl 11():C165-8. PubMed ID: 25381861 [No Abstract] [Full Text] [Related]
77. Different protein expression associated with chemotherapy response in oropharyngeal cancer according to HPV status. Kim MJ; Ki MS; Kim K; Shim HJ; Hwang JE; Bae WK; Chung IJ; Lee DH; Lee JK; Yoon TM; Lim SC; Chung WK; Jeong JU; Lim HS; Choi YD; Cho SH BMC Cancer; 2014 Nov; 14():824. PubMed ID: 25380690 [TBL] [Abstract][Full Text] [Related]
78. Estimating seroprevalence of human papillomavirus type 16 using a mixture model with smoothed age-dependent mixing proportions. Vink MA; van de Kassteele J; Wallinga J; Teunis PF; Bogaards JA Epidemiology; 2015 Jan; 26(1):8-16. PubMed ID: 25380503 [TBL] [Abstract][Full Text] [Related]
79. Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial. Einstein MH; Takacs P; Chatterjee A; Sperling RS; Chakhtoura N; Blatter MM; Lalezari J; David MP; Lin L; Struyf F; Dubin G; Hum Vaccin Immunother; 2014; 10(12):3435-45. PubMed ID: 25483701 [TBL] [Abstract][Full Text] [Related]